脾脏切除对治疗消化道出血效果确切，发生门静脉栓塞1例。
Splenectomy was effective for controlling gastrointestinal bleeding, and its complication of portal vein thrombosis occurred in 1 case.
目的探讨晚期肝门部胆管癌患者经皮经肝门静脉栓塞术的护理。
Objective: Researching the effect of applying selective portal vein embolization (SPVE) in the primary hepatic carcinoma patients.
目的探讨ZT胶行兔选择性门静脉栓塞(SPVE)的安全性及有效性。
Objective To evaluate the safety and efficacy of selective portal vein embolization (SPVE) with ZT glue in rabbit.
目的探讨门静脉栓塞的安全范围及白芨微球作为门静脉栓塞剂的可行性与有效性。
Objective To discuss the safety limit of portal vein embolization, to evaluate the feasibility and efficacy of Bletilla microsphere used as an embolic agent for portal vein.
目的探讨彩色多普勒超声对合并门静脉栓塞者进行肝移植术后并发症的诊断价值。
Objective to evaluate the value of color Doppler ultrasound in diagnosing complications after orthotopic liver transplantation (OLT) in patients with portal vein thrombosis (PVT).
目的：探讨门静脉栓塞(PVE)诱导肝叶代偿性增生临床应用的可行性、安全性、有效性。
OBJECTIVE: to evaluate the feasibility, safety and effectiveness of portal vein embolization (PVE) inducing compensatory hypertrophy of the remnant liver in clinical use.
现综述术前选择性门静脉栓塞术在大肠癌肝转移应用中的病理生理学基础、临床适应证及疗效。
This review will focus on pathophysiological mechanism, clinical indication , and efficacy of PVE in colorectal cancer liver metastases.
目的探讨经导管门静脉栓塞（PVE）诱导肝叶代偿性增生临床应用的可行性、安全性、有效性。
Objective To evaluate the clinical feasibility, safety, and effectiveness of transcatheter portal vein embolization (PVE) inducing compensatory hypertrophy of the remnant liver.
目的探讨术前选择性门静脉栓塞(POSPVE)后不能手术切除的原发性肝癌(HCC)二期切除的可能性。
Objective to determine the possibility of two-stage hepatectomy for primary hepatocellular carcinoma (HCC) after preoperative selective portal vein embolization (POSPVE).
结果既往切脾组肝移植前有2例（12．5％）存在门静脉栓塞，术中切脾组有1例（11．1％）术后发生门静脉栓塞。
Results Two cases (12. 5 %) in group A pre-operation and 1 case (11. 1 %) in group B post-operation had portal vein thrombus.
结论彩色多普勒超声在肝移植术后门静脉并发症的诊断中具有重要的价值，门静脉栓塞的发生原因及预后有待于进一步探讨。
Conclusion Color Doppler ultrasound is important and valuable for diagnosing portal vein complication of liver transplantation. The cause and prediction of thrombosis require further study.
穿刺左中支门静脉，以不同浓度、剂量和推注速度的NBCA栓塞该血管。
Selective puncture to embolize the left-middle portal vein with the different concentration, dosage and the injection speed of NBCA.
目的：观察肝硬化门静脉高压症患者行脾动脉栓塞术前后脾脏及脾静脉血流动力学变化。
Objective: To study the changes of the spleen and splenic venous hemodynamics in liver cirrhosis patients with portal hypertension before and after therapeutic splenic artery embolization.
结果为：①TAE后门静脉血流速度及血流量均较栓塞前增加，而门静脉的内径无明显改变；
The results were: (l)After TAE, portal venous flow and velocity were increased, but portal venous diameter had no significant change.
目的观察肝硬化门静脉高压患者和特发性血小板减少性紫癜(itp)患者行脾动脉栓塞术前后脾脏及脾静脉血流动力学变化。
Objective To study the changes of the spleen and splenic venous hemodynamics in liver cirrhosis patients with portal hypertension and ITP before and after therapeutic splenic artery embolization.
目的探讨胃冠状静脉TH胶栓塞加脾切除术治疗门静脉高压症食管胃底曲张静脉破裂出血的效果。
Objective To study the therapeutic effect of stomach coronary vein TH glue embolism plus lienectomy in the treatment of portal hypertension.
放射介入栓塞化疗对肝癌合并门静脉癌栓治疗的疗效观察。
Transcatheter arterial chemoembolization therapy in the treatment of hepatocellular carcinoma with tumor thrombus of portal vein.
目的探讨脾部分栓塞后脾切除联合门-奇静脉断流术治疗门静脉高压症的护理。
Objective to investigate the nursing effects of combined application of partial splenic embolization with disconnection of portal-systemic venous shunt to treat the portal hypertension.
目的：探讨门静脉癌栓及其栓塞的程度对原发性肝癌的血供的影响。
Objective: To investigate the effect of portal venous cancerous embolism and its degree of embolism on the blood supply of primary hepatic carcinoma (pHC).
结果患者出现门静脉血栓形成，肝栓塞坏死。
Results The patient was found to have destructive damage of portal vein.
目的探讨原发肝癌合并门静脉瘤栓的化学栓塞治疗。
Objective to study the clinical effectiveness of arterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
结论用MSCT血管重建和肝动脉、门静脉双重化疗栓塞治疗转移性肝癌有一定临床效果，且无明显毒副作用。
CONCLUSION: Vascular restructure with MSCT and chemoembolization through portal vein and liver artery, with no obvious side-effects, are effective for patients with liver cancer metastases.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
目的：探讨部分脾动脉栓塞术(PSE)治疗肝炎肝硬化门静脉高压症并发脾功能亢进的疗效及临床意义。
AIM: to study the curative effect and clinical significance of the partial spleen artery embolization (PSE) in the treatment of hepatic cirrhosis together with portal hypertension and hypersplenism.
结果门脉造影显示葡聚糖微球栓塞门静脉末梢分支。
Results Transhepatic portal venography performed after each embolization revealed diffuse PV branch occlusion in all cases.
本文应用彩色多普勒对23例原发性肝细胞癌(HCC)患者肝动脉栓塞术(TAE)前后门静脉的血流动力学变化进行了研究。
Changes of portal venous hemodynamics after transcatheter hepatic artery embolization (TAE) were studied in 23 hepatocellular carcinoma (HCC) patients using the color Doppler system.
目的探讨肝癌合并门静脉癌栓的手术疗效，评价术中门静脉癌栓取出术和术后辅助肝动脉栓塞化疗对提高肝癌术后生存率的影响。
Objective To explore the value of removing portal vein tumor thrombus (PVTT) and TACE in improving the outcome of resection for primary liver cancer with PVTT.
肝静脉栓塞导致肝小叶中心性坏死、硬化与肝静脉-门静脉瘘。
However, embolization of hepatic vein resulted in central necrosis of the lobules, liver cirrhosis and formation of fistulas between the hepatic vein and the portal vein.
结论食管胃底静脉栓塞断流术不仅能减少门静脉高压性上消化道出血复发率降低，同时能改善肝硬化患者的肝功能状况。
Conclusion PTVE not only reduce the recurrence rate of upper gastrointestinal bleeding due to high-pressure portal vein, but also improve the liver function.
应用推荐